Hagiwara et al. examined whether promoter methylation of Checkpoint With Forkhead And Ring Finger Domains (CHFR) gene serves as a predictive biomarker for the efficacy of irinotecan-based systemic chemotherapy in patients with advanced CRC (n = 49). Here, CHFR is linked to colorectal carcinoma.